Sun Pharma Q3 Results FY26: Net Profit at ₹2,523 Crore; Revenue at ₹12,146 Crore Sun Pharmaceutical Industries reported its Q3 Results FY26 with steady revenue growth and margin expansion, supported by continued strength in specialty products and stable performance across domestic and international formulations. The quarter reflects the company’s strategic shift toward high-margin specialty therapies, … Read more
Zydus Lifesciences Q3 Results: Revenue Jumps 30% to ₹6,864 Crore, Profit at ₹1,111 Crore Zydus Lifesciences delivered strong revenue growth in the December quarter, driven by US generics, consumer wellness expansion, and international formulations. Zydus Lifesciences Q3 results show strong top-line growth with improving operating margins, supported by momentum in North America, consumer wellness, and … Read more
Aurobindo Pharma Q3 Results: Profit Rises 7.6% to ₹910 Crore, Europe Drives Growth Aurobindo Pharma reported steady Q3FY26 earnings growth led by strong Europe performance and stable US generics demand. Aurobindo Pharma Q3 results for the December quarter reflected steady earnings growth, supported by strong traction in European markets and stable performance in the US … Read more